Ian Arnott
0000-0003-3352-9253
Publication & Citation Trends
Publications
251 total
Real-world retrospective cohort study of inflammatory bowel disease colorectal cancer surveillance
Cited by 1
Semantic Scholar
Tofacitinib Versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison
Cited by 2
Semantic Scholar
Tu1830 TOFACITINIB VERSUS VEDOLIZUMAB AMONG BIO-NAÏVE PATIENTS WITH ULCERATIVE COLITIS: A REAL-WORLD PROPENSITY-WEIGHTED COMPARISON
Cited by 0
Semantic Scholar
DOP17 Tofacitinib versus Vedolizumab Among Bio-naïve Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison OA
Cited by 0
Semantic Scholar
Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis OA
Cited by 12
Semantic Scholar
O31 Tofacitinib versus vedolizumab among bio-naïve patients with ulcerative colitis: a real-world propensity-weighted comparison
Cited by 1
Semantic Scholar
P860 Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis - a six-year follow-up study OA
Cited by 0
Semantic Scholar
Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis OA
Cited by 28
Semantic Scholar
Mercaptopurine
Cited by 13
Semantic Scholar
Research Topics
Inflammatory Bowel Disease
(171)
Microscopic Colitis
(106)
Eosinophilic Esophagitis
(26)
Helicobacter pylori-related gastroenterology studies
(21)
Acute Lymphoblastic Leukemia research
(19)
Affiliations
Cedars-Sinai Medical Center
NHS Lothian
University of Ulster
University of California, Los Angeles
University of Melbourne